# Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease

> **NCT07556718** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Michigan** · enrollment: 100 (estimated)

## Conditions studied

- Quiescent Crohn's Disease (CD)

## Interventions

- **DRUG:** Amitriptyline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07556718
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556718, "Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07556718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*